References
- Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59(7):845–864. doi: 10.1016/S0016-5107(04)00353-0.
- Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–1788. doi: 10.1111/j.1572-0241.2007.01279.
- Pezzilli R, Romboli E, Campana D, Corinaldesi R. Mechanisms involved in the onset of post-ERCP pancreatitis. JOP. 2002;3(6):162–168.
- Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002;56(4):488–495. doi: 10.1067/mge.2002.128130.
- Keck T, Balcom JH, Antoniu BA, Lewandrowski K, Warshaw AL, Fernández-del Castillo C. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis. Surgery 2001;130(2):175–181.
- Iwaki M, Ino Y, Motoyoshi A, et al. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jpn J Pharmacol. 1986;41(2):155–162.
- Cortesi R, Ascenzi P, Colasanti M, et al. Cross-enzyme inhibition by gabexate mesylate: formulation and reactivity study. J Pharm Sci. 1998;87(11):1335–1340. doi: 10.1021/js980079u.
- Pitkäranta P, Kivisaari L, Nordling S, Nuutinen P, Schroder T. Vascular changes of pancreatic ducts and vessels in acute necrotizing, and in chronic pancreatitis in humans. Int J Pancreatol. 1991;8(1):13–22.
- Nuutinen P, Kivisaari L, Schröder T. Contrast-enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis. Pancreas. 1988;3(1):53–60.
- Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol. 2004;2(8):713–718.
- Jönsson P, Ohlsson K. Intrapancreatic turnover of recombinant human pancreatic secretory trypsin inhibitor in experimental porcine pancreatitis. Scand J Clin Lab Invest 2017;77(3):223–227. Maydoi: 10.1080/00365513.2017.1292539.
- Wakayama T, Itoh T, Shibayama K, Idezuki Y. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs. Am J Gastroenterol 1989;84(3):272–278.
- Tulassay Z, Papp J, Koranyi L, Szathmari M, Tamas G. Jr. Hormonal and biochemical changes following endoscopic retrograde cholangio-pancreatography. Acta Gastroenterol Belg. 1981;44(11–12):538544.
- Kasugai T, Kuno N, Kizu M. Manometric endoscopic retrograde pancreatocholangiography. Digest Dis Sci. 1974;19(6):485–502.
- Zerem E, Imamović G, Sušić A, Haračić B. Step-up approach to infected necrotising pancreatitis: a 20-year experience of percutaneous drainage in a single centre. Dig Liver Dis. 2011;43(6):478–483. doi: 10.1016/j.dld.2011.02.020.
- Zerem E. Reply to: draining sterile fluid collections in acute pancreatitis? Primum non nocere! Surg Endosc. 2011;25(3):979–980. doi: 10.1007/s00464-010-1218-4.
- Besselink MG, van Santvoort HC, Nieuwenhuijs VB, et al. Minimally invasive ‘step-up approach’ versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]. BMC Surg. 2006;6(1):6. doi: 10.1186/1471-2482-6-6.